Earth Science Tech, Inc. (OTC: ETST) has announced the acquisition of Meduvo LLC, a compounding pharmacy based in La Verne, California. This move establishes a West Coast operational hub and expands the company's pharmacy network to 34 U.S. jurisdictions. The acquisition is a significant step in ETST's strategy to build a vertically integrated healthcare platform.
Meduvo currently operates from a 2,000-square-foot facility and specializes in compounding and dispensing non-sterile medications. ETST plans to initiate facility upgrades aimed at meeting sterility requirements, with management targeting full regulatory certification for sterile compounding by the end of 2028. The company also noted that regulatory approvals are pending in additional states as it pursues nationwide coverage.
This acquisition is part of ETST's broader strategy to create a seamless integration of patient care, from consultation to fulfillment. The company's value proposition lies in the synergy of its specialized subsidiaries, which include compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. By expanding its pharmacy network, ETST aims to enhance its ability to serve patients across the country.
The move comes at a time when the demand for compounding pharmacies is growing, driven by the need for personalized medications and the shortage of certain FDA-approved drugs. By adding sterile compounding capabilities, ETST positions itself to meet this demand and potentially capture a larger share of the market.
Investors and industry observers will be watching how ETST executes its expansion plans and navigates regulatory requirements. The company's focus on vertical integration could provide competitive advantages, such as greater control over the supply chain and improved patient outcomes.
For more details, visit the full press release at https://ibn.fm/wMvIu. The latest news and updates on ETST are available in the company's newsroom at https://ibn.fm/ETST.
